Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 14/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 14/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31068338 | 1.00 | DDB1 (0.42) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348627 | 0.88 | DDB1 (0.42) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348444 | 0.85 | DDB1 (0.47) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348452 | 0.83 | DDB1 (0.44) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348198 | 0.81 | DDB1 (0.45) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348202 | 0.81 | DDB1 (0.45) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348199 | 0.81 | DDB1 (0.45) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL31068296 | 0.81 | CRBN (0.42) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348981 | 0.81 | CRBN (0.42) | DDB1CRBNALDH1A1CHRM2OPRM1 | |
| SCHEMBL29348798 | 0.79 | DDB1 (0.42) | DDB1CRBNALDH1A1CHRM2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151547-A1 | TARGETED DEGRADATION OF VAV1 | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |